The price of enVVeno Medical Corporation (NASDAQ: NVNO) closed at $5.44 in the last session, up 3.03% from day before closing price of $5.28. In other words, the price has increased by $+0.16 from its previous closing price. On the day, 54439 shares were traded. NVNO stock price reached its highest trading level at $5.49 during the session, while it also had its lowest trading level at $5.26.
Ratios:
We take a closer look at NVNO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 34.23 and its Current Ratio is at 34.23. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 13 ’24 when Alavi Hamed sold 8,334 shares for $6.22 per share. The transaction valued at 51,837 led to the insider holds 0 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVNO now has a Market Capitalization of 70.31M and an Enterprise Value of 25.30M.
Stock Price History:
Over the past 52 weeks, NVNO has reached a high of $6.97, while it has fallen to a 52-week low of $2.51. The 50-Day Moving Average of the stock is 5.24, while the 200-Day Moving Average is calculated to be 4.67.
Shares Statistics:
According to the various share statistics, NVNO traded on average about 132.01K shares per day over the past 3-months and 88.44k shares per day over the past 10 days. A total of 13.32M shares are outstanding, with a floating share count of 13.27M. Insiders hold about 0.38% of the company’s shares, while institutions hold 37.74% stake in the company. Shares short for NVNO as of Mar 15, 2024 were 856.51k with a Short Ratio of 6.49, compared to 517.11k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 6.43% and a Short% of Float of 6.46%.
Earnings Estimates
The company has 1 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.4 for the current quarter, with a high estimate of -$0.4 and a low estimate of -$0.4, while EPS last year was -$0.57. The consensus estimate for the next quarter is -$0.36, with high estimates of -$0.36 and low estimates of -$0.36.
Analysts are recommending an EPS of between -$1.4 and -$1.4 for the fiscal current year, implying an average EPS of -$1.4. EPS for the following year is -$0.67, with 1 analysts recommending between -$0.67 and -$0.67.
